Comparison of Daytime Surgery in Varicose Veins Patients With and Without Superficial Venous Thrombosis
1 other identifier
observational
699
1 country
1
Brief Summary
Varicose veins of lower extremities are the most common disease in vascular surgery, and daytime surgery has gradually become the mainstream of varicose veins of lower extremities. Superficial venous thrombosis is one of the common complications of varicose veins of lower limbs. Current consensus is that patients with superficial venous thrombosis should be treated with standardized anticoagulant therapy to prevent their progression to venous thrombotic disease.SVT patients need standardized anticoagulant therapy for a period of time, while DS is current mainstream treatment of VV. Will the existence of SVT affect the safety and efficacy of DS of VV, leading a need of changing the treatment strategy and carrying out anticoagulant treatment for SVT before DS on VV patients? To date, there is no research on this issue. Therefore, we conducted this study to comprehensively evaluate the safety, feasibility, perioperative and long-term efficacy of DS in VV patients complicated with SVT, and systematically compared patients who had VV only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2022
CompletedFirst Posted
Study publicly available on registry
May 19, 2022
CompletedStudy Start
First participant enrolled
June 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2025
CompletedMay 19, 2022
May 1, 2022
2 years
May 8, 2022
May 17, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
postoperative deep venous thrombosis
deep venous thrombosis after surgery
Events within one week after surgery
saphenous nerve injury
saphenous nerve injury after surgery
Events during surgery
subcutaneous induration
subcutaneous induration after surgery
Events within one week after surgery
Secondary Outcomes (5)
varicose veins recurrence
recurrence within 12 months follow-up after surgery
superficial venous thrombosis formation
Events within 12 months follow-up after surgery
deep venous thrombosis
Events within 12 months follow-up after surgery
skin burns
Events during surgery
bleeding requiring intervention
Events during surgery
Study Arms (2)
SVT group
Varicose vein patients complicated with superficial thrombophlebitis
Non-SVT group
Patients had varicose vein only
Eligibility Criteria
This is a single center retrospective cohort study, which retrospectively analyzed the clinical data of VV patients treated in Sun Yat-sen Memorial Hospital of Sun Yat-sen University from 2015 to 2021. Doppler ultrasound, combined with clinical examination, was used in the diagnosis of SVT.
You may qualify if:
- VV patients with the CEAP grade of C2-C5;
- At the age 18 to 75;
- Treated by day surgery
You may not qualify if:
- Patient has a history of DVT or is suffering from DVT;
- Patients with liver and renal failure;
- Patients in hypercoagulable state;
- Patients with anticoagulant therapy before operation;
- Patients with active ulcer;
- Patient is intolerant to foam sclerotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
Related Publications (1)
Xu J, Xu X, Tian J, Huang M, Xia Z, Luo X, Zheng J, Huang K. Comparison of day surgery between varicose veins with and without superficial venous thrombosis below knee: a propensity score-matched analysis. BMC Cardiovasc Disord. 2023 Aug 3;23(1):387. doi: 10.1186/s12872-023-03398-2.
PMID: 37537563DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Huang Kai, doctor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2022
First Posted
May 19, 2022
Study Start
June 10, 2022
Primary Completion
June 10, 2024
Study Completion
June 10, 2025
Last Updated
May 19, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share
Clinical treatment information that does not design patient privacy